Get the Stockscreener App
1.08
0.00%
0.00
After Hours:
1.07
-0.01
-0.93%
Therapeuticsmd Inc stock is traded at $1.08, with a volume of 18,788.
It is up +0.00% in the last 24 hours and down -1.82% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.08
Open:
$1.07
24h Volume:
18,788
Relative Volume:
0.59
Market Cap:
$12.50M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.0377
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-2.70%
1M Performance:
-1.82%
6M Performance:
+24.15%
1Y Performance:
-39.33%
1-Day Range:
$1.06
$1.10
1-Week Range:
$1.05
$1.11
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.08 | 12.50M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Price action breakdown for TherapeuticsMD Inc.July 2025 Short Interest & AI Optimized Trading Strategy Guides - Newser
How to track smart money flows in TherapeuticsMD Inc.Market Performance Recap & AI Optimized Trading Strategy Guides - Newser
Does TherapeuticsMD Inc. stock benefit from AI growthCPI Data & Weekly Setup with ROI Potential - خودرو بانک
Will TherapeuticsMD Inc. outperform during market ralliesBuy Signal & Expert-Curated Trade Recommendations - خودرو بانک
How to escape a deep drawdown in TherapeuticsMD Inc.Weekly Gains Summary & Consistent Profit Focused Trading Strategies - Newser
Visual analytics tools that track TherapeuticsMD Inc. performanceTrade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Is TherapeuticsMD Inc. a strong growth stock2025 Big Picture & Fast Moving Trade Plans - خودرو بانک
Will TherapeuticsMD Inc. outperform tech stocksJuly 2025 Highlights & High Accuracy Buy Signal Tips - خودرو بانک
Risk vs reward if holding onto TherapeuticsMD Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - Newser
Should you avoid TherapeuticsMD Inc. stock right nowEarnings Recap Report & Free Real-Time Volume Trigger Notifications - خودرو بانک
Menopause Market: Q1 Revenue of TherapeuticsMD & Growth Forecast to 2032 - newstrail.com
Earnings visualization tools for TherapeuticsMD Inc.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
Developing predictive dashboards with TherapeuticsMD Inc. data2025 Top Decliners & Safe Capital Growth Trade Ideas - Newser
Is TherapeuticsMD Inc. a strong candidate for buy and holdTrade Entry Summary & Risk Controlled Daily Plans - خودرو بانک
Will TherapeuticsMD Inc. outperform the marketEarnings Risk Report & AI Forecast Swing Trade Picks - Newser
Short interest data insights for TherapeuticsMD Inc.Trade Performance Summary & Weekly Top Stock Performers List - Newser
Is TherapeuticsMD Inc. a candidate for recovery playJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
What is the Moat Score of TherapeuticsMD Inc.Day Trade & Smart Investment Allocation Insights - خودرو بانک
Signal strength of TherapeuticsMD Inc. stock in tech scannersWeekly Gains Report & Entry Point Strategy Guides - Newser
When is the best time to exit TherapeuticsMD Inc.Options Play & Long-Term Capital Growth Ideas - Newser
Can TherapeuticsMD Inc. weather a recessionQuarterly Profit Report & Smart Swing Trading Techniques - خودرو بانک
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
How to build a custom watchlist for TherapeuticsMD Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackWall Street Watch & Weekly Top Stock Performers List - Newser
TherapeuticsMD Inc. stock volume spike explainedMarket Movers & Fast Entry Momentum Trade Alerts - Newser
Has TherapeuticsMD Inc. found a price floor2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.Dollar Strength & Real-Time Buy Signal Alerts - Newser
What drives TherapeuticsMD Inc.’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - khodrobank.com
Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Will TherapeuticsMD Inc. stock recover after recent dropDividend Hike & Safe Capital Growth Plans - Newser
Long term hold vs stop loss in TherapeuticsMD Inc.July 2025 Fed Impact & High Conviction Investment Ideas - Newser
Chart based exit strategy for TherapeuticsMD Inc.Trade Risk Assessment & Community Verified Trade Signals - Newser
TherapeuticsMD Inc. stock trend outlook and recovery pathMarket Activity Recap & Verified Entry Point Signals - Newser
Historical volatility pattern of TherapeuticsMD Inc. visualizedQuarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser
Identifying reversal signals in TherapeuticsMD Inc.CEO Change & Weekly Return Optimization Alerts - Newser
TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Will TherapeuticsMD Inc. continue its uptrendQuarterly Trade Report & Precise Swing Trade Alerts - Newser
Should value investors consider TherapeuticsMD Inc.2025 Risk Factors & Fast Gain Swing Alerts - خودرو بانک
How to use Fibonacci retracement on TherapeuticsMD Inc.July 2025 Action & Precise Swing Trade Entry Alerts - Newser
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):